Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).
Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials.
Regulation of Oligodendrocyte Differentiation and Myelination by Nuclear Receptors: Role in Neurodegenerative Disorders.
Gray Matter Segmentation of the Spinal Cord with Active Contours in MR Images.
β-defensin-2 is a responsive biomarker of IL-17A-driven skin pathology in psoriasis.
[Pontine reversible leucopathy in an AIDS patient associated with highly active antiretroviral therapy (HAART): Report of one case].
Multi-Output Decision Trees for Lesion Segmentation in Multiple Sclerosis.
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
Vitamin D as an immune modulator in multiple sclerosis, a review.
Primary Sjögren Syndrome in a Child with a Neuromyelitis Optica Spectrum Disorder.
The recovery trajectory of adolescent social defeat stress-induced behavioral, (1)H-MRS metabolites and myelin changes in Balb/c mice.
Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD.
Cortical thinning in the anterior cingulate cortex predicts multiple sclerosis patients' fluency performance in a lateralised manner.
Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis.
Disease modifying therapies for relapsing multiple sclerosis.
Role of the α7 nicotinic acetylcholine receptor and RIC-3 in the cholinergic anti-inflammatory pathway.
Automated tissue segmentation of MR brain images in the presence of white matter lesions.
Fingolimod suppresses bone resorption in female patients with multiple sclerosis.
Persistence and adherence in multiple sclerosis patients starting glatiramer acetate treatment: assessment of relationship with care received from multiple disciplines.
The Corpus Callosum and Forensic Issues-An Overview.
CDR3 sequence preference of TCRBV8S2+ T cells within the CNS does not reflect single amino acid dependent avidity expansion.
Clinical and epidemiological profile of patients diagnosed with multiple sclerosis in João Pessoa, Paraíba, Brazil.
Health Literacy and Outcomes in Multiple Sclerosis.
An update on the causes, assessment and management of third division sensory trigeminal neuropathies.
Brain health: time matters in multiple sclerosis.
Pages
« first
‹ previous
…
749
750
751
752
753
754
755
756
757
…
next ›
last »